Text to be removed highlighted in red.
1 Purpose. The purpose of this act is to inform women seeking chemical abortions that it may be possible to undo the effects of mifepristone, a drug commonly used to induce abortions.
2 New Subdivision; Chemical Abortion. Amend RSA 329 by inserting after section 53 the following new subdivision:
Chemical Abortion
329:54 Definitions. In this subdivision:
I. "Chemical abortion" or "medical abortion" means the use or prescription of any drug or chemical for the purposes of inducing an abortion including, but not limited to, mifepristone.
II. "Medical facility" shall have the same meaning as defined in RSA 329:43, VI.
329:55 Notice.
I. Any medical facility or pharmacy in New Hampshire where any chemical abortion drug is prescribed, dispensed, or administered for the purposes of inducing a medical abortion shall post a conspicuous sign at least 8.5 inches by 11 inches that is clearly visible to patients and customers. Such sign shall be printed with lettering that is legible and at least 3/4 of an inch boldfaced type and shall read:
"NOTICE TO PATIENTS HAVING CHEMICAL ABORTIONS THAT USE MIFEPRISTONE OR OTHER CHEMICAL ABORTION DRUG: Mifepristone, also known as 'RU-486,' alone is not always effective in ending a pregnancy. It may be possible to reverse its intended effect if the second pill or tablet has not been taken or administered. If you change your mind and wish to continue the pregnancy, you can get immediate help by accessing available resources, including Option Line by Heartbeat International at insert phone number here."
II. Any private office or freestanding surgical outpatient clinic where mifepristone is prescribed, dispensed, or administered for the purposes of inducing a medical abortion shall post the sign required under paragraph I in each patient waiting room and patient consultation room used by patients seeking medical abortions.
III. A hospital or other medical care facility or clinic where mifepristone is prescribed, dispensed, or administered for the purposes of inducing a medical abortion that is not a private office or freestanding surgical outpatient clinic shall post the sign required under paragraph I in each patient admission area.
IV. A pharmacy where mifepristone is prescribed, dispensed, or administered for the purpose of inducing a medication abortion shall post the sign required under paragraph I in the area inside the premises where customers are provided prescription medications, and on the exterior of the premises in the area where customers are provided prescription medications via a drive-through window.
329:56 Enforcement.
I. A health care provider or pharmacy that knowingly violates RSA 329:55 shall be guilty of a class B felony.
II. Any woman prescribed, dispensed, or administered a drug intending to induce a chemical abortion without being informed by the notice outlined under RSA 329:55 may, in a civil action, obtain appropriate relief against the party in violation of RSA 329:55. Such relief shall include monetary damages for any psychological or physical injuries, or both, caused by a violation of this subdivision.
3 Effective Date. This act shall take effect 60 days after its passage.
Text to be added highlighted in green.
1 Purpose. The purpose of this act is to inform women seeking chemical abortions that it may be possible to undo the effects of mifepristone, a drug commonly used to induce abortions.
2 New Subdivision; Chemical Abortion. Amend RSA 329 by inserting after section 53 the following new subdivision:
Chemical Abortion
329:54 Definitions. In this subdivision:
I. "Chemical abortion" or "medical abortion" means the use or prescription of any drug or chemical for the purposes of inducing an abortion including, but not limited to, mifepristone.
II. "Medical facility" shall have the same meaning as defined in RSA 329:43, VI.
329:55 Notice.
I. Any medical facility or pharmacy in New Hampshire where any chemical abortion drug is prescribed, dispensed, or administered for the purposes of inducing a medical abortion shall post a conspicuous sign at least 8.5 inches by 11 inches that is clearly visible to patients and customers. Such sign shall be printed with lettering that is legible and at least 3/4 of an inch boldfaced type and shall read:
"NOTICE TO PATIENTS HAVING CHEMICAL ABORTIONS THAT USE MIFEPRISTONE OR OTHER CHEMICAL ABORTION DRUG: Mifepristone, also known as 'RU-486,' alone is not always effective in ending a pregnancy. It may be possible to reverse its intended effect if the second pill or tablet has not been taken or administered. If you change your mind and wish to continue the pregnancy, you can get immediate help by accessing available resources, including Option Line by Heartbeat International at ."
II. Any private office or freestanding surgical outpatient clinic where mifepristone is prescribed, dispensed, or administered for the purposes of inducing a medical abortion shall post the sign required under paragraph I in each patient waiting room and patient consultation room used by patients seeking medical abortions.
III. A hospital or other medical care facility or clinic where mifepristone is prescribed, dispensed, or administered for the purposes of inducing a medical abortion that is not a private office or freestanding surgical outpatient clinic shall post the sign required under paragraph I in each patient admission area.
IV. A pharmacy where mifepristone is prescribed, dispensed, or administered for the purpose of inducing a medication abortion shall post the sign required under paragraph I in the area inside the premises where customers are provided prescription medications, and on the exterior of the premises in the area where customers are provided prescription medications via a drive-through window.
329:56 Enforcement.
I. A health care provider or pharmacy that knowingly violates RSA 329:55 shall be guilty of a class B felony.
II. Any woman prescribed, dispensed, or administered a drug intending to induce a chemical abortion without being informed by the notice outlined under RSA 329:55 may, in a civil action, obtain appropriate relief against the party in violation of RSA 329:55. Such relief shall include monetary damages for any psychological or physical injuries, or both, caused by a violation of this subdivision.
3 Effective Date. This act shall take effect 60 days after its passage.